GUANIDINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Guanidine Hydrochloride patents expire, and what generic alternatives are available?
Guanidine Hydrochloride is a drug marketed by Merck Sharp Dohme and is included in one NDA.
The generic ingredient in GUANIDINE HYDROCHLORIDE is guanidine hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the guanidine hydrochloride profile page.
Summary for GUANIDINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 176 |
Clinical Trials: | 8 |
Patent Applications: | 318 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in GUANIDINE HYDROCHLORIDE? | GUANIDINE HYDROCHLORIDE excipients list |
DailyMed Link: | GUANIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for GUANIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Hospital of Fudan University | Phase 4 |
Washington University School of Medicine | Early Phase 1 |
St. Louis University | Early Phase 1 |
US Patents and Regulatory Information for GUANIDINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck Sharp Dohme | GUANIDINE HYDROCHLORIDE | guanidine hydrochloride | TABLET;ORAL | 001546-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |